Pharmaceutical manufacturers are accelerating investment in direct-to-patient models as policy shifts and rising consumer expectations reshape the industry landscape. Chip Parkinson, CEO of Gifthealth, says the momentum behind these integrated models has
Pharma’s third-party logistics sector is undergoing a fundamental transformation, moving well beyond its traditional role of shifting pallets through wholesale distribution chains. The industry is now contending with smaller patient populations, highly
MoreThis year’s American Association of Law Libraries annual meeting drew attention for its notably themed focus, signalling a deliberate shift in the organisation’s priorities. AALL, as the body is widely known, has
MoreChina’s economy expanded at its weakest pace in more than three years during the second quarter of 2026, falling short of analyst expectations. Gross domestic product grew 4.3% in the April to
MoreBritain’s buy now, pay later sector is entering a new era after nearly five years of regulatory delay finally gave way to formal oversight. The Financial Conduct Authority assumed authority over the
MoreOn June 30, 2026, California’s Governor’s Office of Land Use and Climate Innovation released final guidance for the Assembly Bill 130 Statewide Vehicle Miles Traveled Mitigation Program. The final guidance largely preserves
MoreJustice Amy Coney Barrett is facing scrutiny over an apparent contradiction in her stated views on Supreme Court transparency and accountability. Back in 2021, Barrett urged Americans to “read the opinion” and
MoreHubSpot (HUBS), Workday (WDAY), and Asana (ASAN) all traded lower in recent sessions, drawing attention from investors tracking the enterprise software sector. The three companies operate across overlapping segments of the business
MoreJohnson Matthey, the FTSE-listed specialty chemicals and sustainable technologies group, has come under increasing scrutiny from investors weighing whether the stock represents value. The London-based company, which trades on the London Stock
MoreThe Trump administration’s April 2026 announcement of a 100% base levy on imported APIs and patented drugs has forced a sweeping re-evaluation of pharmaceutical supply chains across the industry. Reshoring pharmaceutical manufacturing
MoreChristopher Boehning and Daniel Levi, both senior litigators, have departed Paul Weiss to join the New York office of Linklaters. Boehning, who served as FIFA’s lead counsel, will chair a newly created
More
